Uniqure NV (NASDAQ:QURE)
| 22.54 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 12.52 Today|||52-Week Range 28.26 | -0.57% Year-to-Date |
Latest QURE News | Press Releases
No recent news for Uniqure NV.
Today’s Trading
| Previous close | 22.54 |
| Today’s open | 21.97 |
| Day’s range | 21.92 - 22.71 |
| Volume | 14,910 |
| Average volume (3 months) | 647,063 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -153.22% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +1,296.82% |
| P/E ratio | NM |
| Price/Sales | 1.85 |
| Price/Book | 1.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| COGTCogent Biosciences I... | -0.32 | -2.06% |
| IMGNImmunoGen Inc | +0.01 | +0.21% |
| RGNXRegenxbio Inc | -0.32 | -1.33% |
| CDMOAvid Bioservices Inc | -0.45 | -2.71% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.89 |
| Annual revenue (last year) | $524.0M |
| Annual profit (last year) | $329.6M |
| Net profit margin | 62.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
